NCT07097363
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Primary Mediastinal Large B-Cell Lymphoma
Explore clinical trials studying Primary Mediastinal Large B-Cell Lymphoma. Study availability and eligibility vary by location and protocol.
16 public trials
6 recruiting studies
Primary Mediastinal Large B-Cell Lymphoma trial results
NCT06550141
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
NCT06784167
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Recruiting
Immunotherapy in Lymphoma
NCT06796517
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma Relapsed, +22 more
- Locations
-
- Seoul St. Mary Hospital Seoul, South Korea
- Yeoido St. Mary Hospital Seoul, South Korea
NCT06238648
- Conditions
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Siteman Cancer Center at Washington University St Louis, Missouri, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT04824950
- Conditions
- Primary Mediastinal Large B-Cell Lymphoma
- Locations
-
- Centre Hospitalier Lyon Sud Lyon, France
- Centre Henri Becquerel Rouen, France
Not yet recruiting
Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
NCT07714421
- Conditions
- Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Enrolling by invitation
Long-term Study to Evaluate Safety and Persistence of GF-CART01
NCT06985576
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Follicular Lymphoma (FL), +14 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Active, not recruiting
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
NCT04759586
- Conditions
- Primary Mediastinal Large B-Cell Lymphoma
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
Active, not recruiting
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
NCT04231877
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States